InVivo Therapeutics Holdings Corp logo

InVivo Therapeutics Holdings Corp

FRA:04I (USA)  
€ 0.25 (0%) Feb 26
At Loss
Market Cap:
€ 847.00K ($ 939.00K)
Enterprise V:
€ -7.08M ($ -7.85M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 45.06
9-Day RSI 40.82
14-Day RSI 40.29
6-1 Month Momentum % -45.6
12-1 Month Momentum % -70.36

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History